Clerkenwell Health is set to open Europe’s first commercial facility for psychedelic drug trials in London, with the goal of making the UK a global leader in psychedelics research and innovation.
Companies Featured
Clerkenwell HealthClerkenwell is a clinical research organisation (CRO) in the UK that supports drug developers as they attempt to commercialise psychedelic therapies. Clerkenwell offers support from preclinical studies up to Phase III of the drug development process.